Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.72% | 4.10% | 3.38% | 60.68% | 64.31% |
| Total Depreciation and Amortization | -8.56% | -7.94% | -4.76% | 23.33% | 70.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.58% | 22.85% | -18.66% | -97.69% | -97.06% |
| Change in Net Operating Assets | -128.13% | -88.96% | 128.14% | 108.46% | 104.56% |
| Cash from Operations | 6.00% | 3.37% | 15.75% | 12.62% | 20.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.71% | 30.99% | -73.29% | 51.44% | -71.44% |
| Cash from Investing | 32.48% | 30.99% | -73.26% | 90.91% | -68.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -39.50% | -85.71% | -87.98% | -87.98% | 1,006.98% |
| Repurchase of Common Stock | -153.38% | -201.10% | -56.04% | 19.57% | 19.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -126.52% | -153.51% | -122.93% | -132.62% | 332.62% |
| Foreign Exchange rate Adjustments | 103.13% | -243.75% | -178.57% | -20.00% | -276.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.99% | 33.23% | -1,459.89% | 147.66% | -141.21% |